ESR2 and neoplasm: These findings suggested a tumor-promoting role of ERβ5 in ECs, which is supported by the fact that the expression of ERβ5 and of two other ERβ variants was particularly elevated in G3 tumors when compared to G1 or G2 tumors or to postmenopausal endometrium [28].